Cole K, Kohn E
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.
Cancer Metastasis Rev. 1994 Mar;13(1):31-44. doi: 10.1007/BF00690417.
The process of proliferation, invasion and metastasis is a complex one which involves both the autonomy of the malignant cells and their interaction with the cellular and extracellular environments. The way in which the tumor cells respond to cellular and extracellular stimuli is regulated through transduction of those signals and translation into cellular activity. Transmembrane signal transduction involves three major categories of events: ion channel activation, transmission through guanine nucleotide binding protein intermediates with production of second messengers, and phosphorylation events. A frequent common denominator of these different pathways is a cellular calcium homeostasis. Calcium may be both a result of and a regulator of many of these signal transduction pathways and has been shown to have a role in the regulation of proliferation, invasion, and metastatic potential. The understanding and application of the basic tenets of these pathways to tumor cell proliferation, invasion, and metastases opens a new target for therapeutic intervention. We have identified a novel agent, CAI, which through inhibition of stimulated calcium influx inhibits proliferation and migration in vitro, and growth and dissemination in human cancer xenografts in vivo. CAI offers a new approach to cancer therapy, signal transduction therapy.
增殖、侵袭和转移过程是一个复杂的过程,它涉及恶性细胞的自主性及其与细胞内和细胞外环境的相互作用。肿瘤细胞对细胞内和细胞外刺激作出反应的方式是通过这些信号的转导并转化为细胞活性来调节的。跨膜信号转导涉及三大类事件:离子通道激活、通过鸟嘌呤核苷酸结合蛋白中间体进行传递并产生第二信使,以及磷酸化事件。这些不同途径的一个常见共同特征是细胞钙稳态。钙可能既是许多这些信号转导途径的结果,也是其调节因子,并且已被证明在增殖、侵袭和转移潜能的调节中发挥作用。对这些途径的基本原理在肿瘤细胞增殖、侵袭和转移方面的理解和应用为治疗干预开辟了一个新靶点。我们已经鉴定出一种新型药物CAI,它通过抑制刺激后的钙内流在体外抑制增殖和迁移,并在体内抑制人癌异种移植瘤的生长和扩散。CAI为癌症治疗提供了一种新方法,即信号转导疗法。